The research and development is focused on a compliant shape memory device for meniscal repair. Additional funding phases could mean the total award would equal over $1.5 million if the company achieves the target Phase I development milestones.
The company is developing crescent-shaped pads of fibrocartilage located between the femur and tibia to act as shock absorbers preventing friction between the bones. The pads also help with stabilization and protect articular cartilage on the impacted surfaces.
Related Articles on Orthopedic Devices:
Smith & Nephew Stocks Soar Amid Takeover Rumors
Patent Infringement Trial Underway for Medtronic and NuVasive
Stryker Takes Mobile Training Center on the Road to China
